StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$19.87+1.27 (+6.83%)

Close on Nov 16, 2026Market cap $109.16MP/E –Yield –

InMed Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

InMed Pharmaceuticals's price to sales ratio was 0.4× on Apr 30, 2026, against 0.4× a year earlier. Over the last 4 years it ranged from 0.2× to 9.3×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.4×−0.1
2025Dec 31, 20250.6×−0.1
2024Dec 31, 20240.6×+0.3
2023Dec 29, 20230.3×−1.0
2022Dec 30, 20221.3×−5.1
2021Oct 29, 20216.4×–

More InMed Pharmaceuticals figures

See a number that looks wrong?